Primary drug resistance patterns in newly diagnosed tuberculosis patients in Yazd, Southern Province of Iran

Primary drug resistance patterns in newly diagnosed tuberculosis patients in Yazd, Southern Province of Iran

Prevalence of multidrug resistant (MDR) and extensively drug-resistant tuberculosis (XDR) has been a cause of concern for tuberculosis (TB) control in both developed and developing countries. The objective of this study was to investigate the prevalence of drug resistance patterns among newly diagno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:African journal of biotechnology 2012-01, Vol.11 (3), p.702-706
Hauptverfasser: Yazdi, SMK, Jabbari, H, Dallal, SMM, Bahrmand, A
Format: Artikel
Sprache:eng
Schlagworte:
Mycobacterium
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 706
container_issue 3
container_start_page 702
container_title African journal of biotechnology
container_volume 11
creator Yazdi, SMK
Jabbari, H
Dallal, SMM
Bahrmand, A
description Prevalence of multidrug resistant (MDR) and extensively drug-resistant tuberculosis (XDR) has been a cause of concern for tuberculosis (TB) control in both developed and developing countries. The objective of this study was to investigate the prevalence of drug resistance patterns among newly diagnosed tuberculosis cases, in Yazd, the southern province of Iran, during 2009 to 2010. The drug susceptibility testing (DST) was performed for 31 culture-positive individuals. The strains that were identified as MDR were subjected to susceptibility testing for second line drugs. The highest rate of resistance was to ethinoamide (51.61%), followed by kanamycin (29.03%), streptomycin (25.8%), rifampine (22.58%), isoniazid (6.45%), and ethambutol (3.2%). Drug resistance to both isoniazid and rifampin was identified in 2 cases.
doi_str_mv 10.5897/AJB11.3303
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1020844972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1020844972</sourcerecordid><originalsourceid>FETCH-LOGICAL-c179t-22933a343a7ba5d5b7ec71657e325c412bbc8d601693f0007fa472d0bfcc67553</originalsourceid><addsrcrecordid>eNpN0D1PwzAQgGELgUQpLPwCjwiR4s84GUtVoKgSlYCBKXKcSwlK7WI7IPj1JC0D093w3A0vQueUTGSWq-vpww2lE84JP0AjmmYikZzKw3_7MToJ4Z0QxpkgI9SufLPR_htXvltjD6EJUVsDeKtjBG8Dbiy28NX2otFr6wJUOHYleNO1rtcDbMDGHXzVP9UVfnJdfOtv8cq7z2Z45mq88NqeoqNatwHO_uYYvdzOn2f3yfLxbjGbLhNDVR4TxnLONRdcq1LLSpYKjKKpVMCZNIKysjRZlRKa5rwmhKhaC8UqUtbGpEpKPkYX-79b7z46CLHYNMFA22oLrgsFJYxkQuSK9fRyT413IXioi-0-SI-KIWmxS1oMSfkv9lJp_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1020844972</pqid></control><display><type>article</type><title>Primary drug resistance patterns in newly diagnosed tuberculosis patients in Yazd, Southern Province of Iran</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Yazdi, SMK ; Jabbari, H ; Dallal, SMM ; Bahrmand, A</creator><creatorcontrib>Yazdi, SMK ; Jabbari, H ; Dallal, SMM ; Bahrmand, A</creatorcontrib><description>Prevalence of multidrug resistant (MDR) and extensively drug-resistant tuberculosis (XDR) has been a cause of concern for tuberculosis (TB) control in both developed and developing countries. The objective of this study was to investigate the prevalence of drug resistance patterns among newly diagnosed tuberculosis cases, in Yazd, the southern province of Iran, during 2009 to 2010. The drug susceptibility testing (DST) was performed for 31 culture-positive individuals. The strains that were identified as MDR were subjected to susceptibility testing for second line drugs. The highest rate of resistance was to ethinoamide (51.61%), followed by kanamycin (29.03%), streptomycin (25.8%), rifampine (22.58%), isoniazid (6.45%), and ethambutol (3.2%). Drug resistance to both isoniazid and rifampin was identified in 2 cases.</description><identifier>ISSN: 1684-5315</identifier><identifier>EISSN: 1684-5315</identifier><identifier>DOI: 10.5897/AJB11.3303</identifier><language>eng</language><subject>Mycobacterium</subject><ispartof>African journal of biotechnology, 2012-01, Vol.11 (3), p.702-706</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c179t-22933a343a7ba5d5b7ec71657e325c412bbc8d601693f0007fa472d0bfcc67553</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Yazdi, SMK</creatorcontrib><creatorcontrib>Jabbari, H</creatorcontrib><creatorcontrib>Dallal, SMM</creatorcontrib><creatorcontrib>Bahrmand, A</creatorcontrib><title>Primary drug resistance patterns in newly diagnosed tuberculosis patients in Yazd, Southern Province of Iran</title><title>African journal of biotechnology</title><description>Prevalence of multidrug resistant (MDR) and extensively drug-resistant tuberculosis (XDR) has been a cause of concern for tuberculosis (TB) control in both developed and developing countries. The objective of this study was to investigate the prevalence of drug resistance patterns among newly diagnosed tuberculosis cases, in Yazd, the southern province of Iran, during 2009 to 2010. The drug susceptibility testing (DST) was performed for 31 culture-positive individuals. The strains that were identified as MDR were subjected to susceptibility testing for second line drugs. The highest rate of resistance was to ethinoamide (51.61%), followed by kanamycin (29.03%), streptomycin (25.8%), rifampine (22.58%), isoniazid (6.45%), and ethambutol (3.2%). Drug resistance to both isoniazid and rifampin was identified in 2 cases.</description><subject>Mycobacterium</subject><issn>1684-5315</issn><issn>1684-5315</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpN0D1PwzAQgGELgUQpLPwCjwiR4s84GUtVoKgSlYCBKXKcSwlK7WI7IPj1JC0D093w3A0vQueUTGSWq-vpww2lE84JP0AjmmYikZzKw3_7MToJ4Z0QxpkgI9SufLPR_htXvltjD6EJUVsDeKtjBG8Dbiy28NX2otFr6wJUOHYleNO1rtcDbMDGHXzVP9UVfnJdfOtv8cq7z2Z45mq88NqeoqNatwHO_uYYvdzOn2f3yfLxbjGbLhNDVR4TxnLONRdcq1LLSpYKjKKpVMCZNIKysjRZlRKa5rwmhKhaC8UqUtbGpEpKPkYX-79b7z46CLHYNMFA22oLrgsFJYxkQuSK9fRyT413IXioi-0-SI-KIWmxS1oMSfkv9lJp_Q</recordid><startdate>20120110</startdate><enddate>20120110</enddate><creator>Yazdi, SMK</creator><creator>Jabbari, H</creator><creator>Dallal, SMM</creator><creator>Bahrmand, A</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20120110</creationdate><title>Primary drug resistance patterns in newly diagnosed tuberculosis patients in Yazd, Southern Province of Iran</title><author>Yazdi, SMK ; Jabbari, H ; Dallal, SMM ; Bahrmand, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c179t-22933a343a7ba5d5b7ec71657e325c412bbc8d601693f0007fa472d0bfcc67553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Mycobacterium</topic><toplevel>online_resources</toplevel><creatorcontrib>Yazdi, SMK</creatorcontrib><creatorcontrib>Jabbari, H</creatorcontrib><creatorcontrib>Dallal, SMM</creatorcontrib><creatorcontrib>Bahrmand, A</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>African journal of biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yazdi, SMK</au><au>Jabbari, H</au><au>Dallal, SMM</au><au>Bahrmand, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary drug resistance patterns in newly diagnosed tuberculosis patients in Yazd, Southern Province of Iran</atitle><jtitle>African journal of biotechnology</jtitle><date>2012-01-10</date><risdate>2012</risdate><volume>11</volume><issue>3</issue><spage>702</spage><epage>706</epage><pages>702-706</pages><issn>1684-5315</issn><eissn>1684-5315</eissn><abstract>Prevalence of multidrug resistant (MDR) and extensively drug-resistant tuberculosis (XDR) has been a cause of concern for tuberculosis (TB) control in both developed and developing countries. The objective of this study was to investigate the prevalence of drug resistance patterns among newly diagnosed tuberculosis cases, in Yazd, the southern province of Iran, during 2009 to 2010. The drug susceptibility testing (DST) was performed for 31 culture-positive individuals. The strains that were identified as MDR were subjected to susceptibility testing for second line drugs. The highest rate of resistance was to ethinoamide (51.61%), followed by kanamycin (29.03%), streptomycin (25.8%), rifampine (22.58%), isoniazid (6.45%), and ethambutol (3.2%). Drug resistance to both isoniazid and rifampin was identified in 2 cases.</abstract><doi>10.5897/AJB11.3303</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1684-5315
ispartof African journal of biotechnology, 2012-01, Vol.11 (3), p.702-706
issn 1684-5315
1684-5315
language eng
recordid cdi_proquest_miscellaneous_1020844972
source EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry
subjects Mycobacterium
title Primary drug resistance patterns in newly diagnosed tuberculosis patients in Yazd, Southern Province of Iran
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T01%3A05%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20drug%20resistance%20patterns%20in%20newly%20diagnosed%20tuberculosis%20patients%20in%20Yazd,%20Southern%20Province%20of%20Iran&rft.jtitle=African%20journal%20of%20biotechnology&rft.au=Yazdi,%20SMK&rft.date=2012-01-10&rft.volume=11&rft.issue=3&rft.spage=702&rft.epage=706&rft.pages=702-706&rft.issn=1684-5315&rft.eissn=1684-5315&rft_id=info:doi/10.5897/AJB11.3303&rft_dat=%3Cproquest_cross%3E1020844972%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1020844972&rft_id=info:pmid/&rfr_iscdi=true